EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail
BRUSSELS (AP) - The European Union on Thursday ordered U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal wi…
